The strong revenue growth, improved margins, and successful capital raise position TriSalus well for executing its 2026 growth plans. The reaffirmed guidance suggests confidence in continued momentum.
Price Chart
Executive Summary
TriSalus Life Sciences reported strong financial results for Q4 and full-year 2025, with revenue of $13.2 million (up 60% YoY) and $45.2 million for the year (up 53% YoY). The company reaffirmed its 2026 revenue guidance of $60-62 million and raised $46 million in gross proceeds from a recent public offering to support growth initiatives.
Key Financial Metrics
Key Facts
- Q4 2025 revenue was $13.2 million, a 60% increase year-over-year
- Full-year 2025 revenue was $45.2 million, a 53% increase year-over-year
- Gross margin increased to 86.7% in Q4 2025 from 85.3% in Q4 2024
- Adjusted EBITDA loss improved to $0.9 million in Q4 2025 from $5.7 million in Q4 2024
- Company reaffirmed 2026 revenue guidance of $60-62 million
- Raised $46 million in gross proceeds from a recent public offering
Financial Impact
Revenue growth of 53% for full-year 2025 and 60% for Q4 2025, with $46 million in new capital raised
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| TriNav system | $45.2M | +53.0% |
Risk Factors
- The company continues to report net losses, with net loss attributable to common stockholders of $69.7 million for 2025
- Gross margin for full-year 2025 decreased to 84.6% from 86.1% in 2024 due to lower manufacturing efficiency with new products
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-015155 |
| Document: tlsi-20260305.htm | 0001628280-26-015155 |
| Document: 0001628280-26-015155-index-headers.html | 0001628280-26-015155 |
| Document: 0001628280-26-015155-index.html | 0001628280-26-015155 |
| Document: 0001628280-26-015155.txt | 0001628280-26-015155 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 19w ago | Institutional Cluster | $3.64 $5.00 | ▲ +37.36% | ▲ +32.97% | $3.80 (+4.40%) |
Jun 11, 2026 19w ago | Institutional Cluster | $3.64 $5.00 | ▲ +37.36% | ▲ +32.97% | $3.80 (+4.40%) |
Mar 11, 2026 32w ago | Insider Cluster | $4.16 $3.18 | ▼ −23.56% | ▼ −35.08% | $3.80 (−8.65%) |
Mar 5, 2026 33w ago | 8-K | $4.47 $3.67 | ▼ −17.81% | ▼ −30.59% | $3.80 (−14.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers